Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

NET 1Gastrointestinal 1Endocrine 1

Conditions

Lung Neoplasms 22Carcinoma, Non-Small-Cell Lung 15Ovarian Neoplasms 13Fallopian Tube Neoplasms 12Carcinoma, Hepatocellular 9Colorectal Neoplasms 8Urinary Bladder Neoplasms 7Pancreatic Neoplasms 7Melanoma 6Lymphoma, Large B-Cell, Diffuse 6Mycosis Fungoides 5Leukemia, Lymphocytic, Chronic, B-Cell 5Carcinoma, Renal Cell 5Squamous Cell Carcinoma of Head and Neck 4Neoplasm Metastasis 4Lymphoma, T-Cell, Cutaneous 4Glioblastoma 4Colonic Neoplasms 4Breast Neoplasms 4Triple Negative Breast Neoplasms 3Thyroid Neoplasms 3Sezary Syndrome 3Rectal Neoplasms 3Nasopharyngeal Carcinoma 3Multiple Myeloma 3Mouth Neoplasms 3Lymphoma, T-Cell 3Lymphoma, B-Cell 3Endometrial Neoplasms 3Cholangiocarcinoma 3

Interventions

lutetium Lu 177 dotatate 6Octreotide 3pasireotide 2lanreotide 2gallium Ga 68 dotatate 2copper dotatate CU-64 2amino-acid, glucose, and electrolyte solution 2Magnetic Resonance Spectroscopy 2Lutetium-177 2Lutetium 2Ga(III)-DOTATOC 2Everolimus 2177Lu-octreotide, DOTA(0)-Tyr(3)- 2zimberelimab 1irinotecan sucrosofate 1abemaciclib 1X-Rays 1Temozolomide 1Sunitinib 1Receptor-Like Protein Tyrosine Phosphatases, Class 2 1Radiosurgery 1PM 01183 1Oxaliplatin 1Nivolumab 1Leucovorin 1Irinotecan 1Ipilimumab 1Folfox protocol 1Fluorouracil 1E-7386 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gastro-enteropancreatic neuroendocrine tumor × Disulfides × 1 year × Clear all
NCT04609592 2025-09-09

Study of PRRT in Metastatic, World Health Organization (WHO) Grade 1 or 2, SSTR Positive, GEP-NET Who Are Candidates for Cytoreductive Surgery

Stanford University

Phase 1 Recruiting
10 enrolled
EndocrineGastrointestinalNET

Gastro-enteropancreatic neuroendocrine tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡